1 Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 323, 1239-1242 (2020).
2 Gengler, I., Wang, J. C., Speth, M. M. & Sedaghat, A. R. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. Laryngoscope Investig Otolaryngol. 5, 354-359, doi:10.1002/lio2.384 (2020).
3 Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 382, 1177-1179 (2020).
4 Tong, J. Y., Wong, A., Zhu, D., Fastenberg, J. H. & Tham, T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 163, 3-11, doi:10.1177/0194599820926473 (2020).
5 Kim, G.-u. et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect., doi: 10.1016/j.cmi.2020.04.040 (2020).
6 Lee, Y., Min, P., Lee, S. & Kim, S.-W. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 35 (2020).
7 Liang, Y. et al. Neurosensory dysfunction: a diagnostic marker of early COVID-19. Int J Infect Dis., doi: 10.1016/j.ijid.2020.06.086 (2020).
8 Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurol. 77, 683-690 (2020).
9 Noh, J. Y. et al. Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration. J Infect., doi: 10.1016/j.jinf.2020.05.035 (2020).
10 Abalo-Lojo, J. M., Pouso-Diz, J. M. & Gonzalez, F. Taste and Smell Dysfunction in COVID-19 Patients. Ann Otol Rhinol Laryngol., doi: 10.1177/0003489420932617 (2020).
11 Aggarwal, S. et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis 7, 91-96 (2020).
12 Altin, F., Cingi, C., Uzun, T. & Bal, C. Olfactory and gustatory abnormalities in COVID-19 cases. Eur Arch Otorhinolaryngol., 1-7 (2020).
13 Beltrán‐Corbellini, Á. et al. Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study. Eur J neurol., doi: 10.1111/ene.14273 (2020).
14 Biadsee, A. et al. Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms—A Potential Pathway to Early Diagnosis. Otolaryngol Head Neck Surg., doi: 10.1177/0194599820934380 (2020).
15 Brandstetter, S. et al. Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak. Pediatr Allergy Immunol., doi: 10.1111/pai.13278 (2020).
16 Carignan, A. et al. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case− control study. CMAJ, doi: 10.1503/cmaj.200869 (2020).
17 Chua, A. J. K., Chan, E. C. Y., Loh, J. & Charn, T. C. Acute olfactory loss is specific for Covid-19 at the Emergency Department. Ann Emerg Med., doi: 10.1016/j.annemergmed.2020.05.015. (2020).
18 Dawson, P. et al. Loss of Taste and Smell as Distinguishing Symptoms of COVID-19. Clin Infect Dis., doi: 10.1093/cid/ciaa799 (2020).
19 De Maria, A., Varese, P., Dentone, C., Barisione, E. & Bassetti, M. High prevalence of olfactory and taste disorder during SARS‐CoV‐2 infection in outpatients. J Med Virol., doi: 10.1002/jmv.25995. (2020).
20 Dell’Era, V. et al. Smell and taste disorders during COVID‐19 outbreak: A cross‐sectional study on 355 patients. Head Neck., doi: 10.1002/hed.26288 (2020).
21 Freni, F. et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2. Am J Otolaryngol., doi: 10.1016/j.amjoto.2020.102612. (2020).
22 Gelardi, M., Trecca, E., Cassano, M. & Ciprandi, G. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report. Acta Biomed. 91, 230-231 (2020).
23 Iravani, B. et al. Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population. Chem Senses., doi: 10.1093/chemse/bjaa034 (2020).
24 Izquierdo-Domínguez, A. et al. Smell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings-a multicenter cross-sectional study. J Investig Allergol Clin Immunol., doi: 10.18176/jiaci.0595 (2020).
25 Karadaş, Ö., Öztürk, B. & Sonkaya, A. R. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci., 1-5 (2020).
26 Lagi, F. et al. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 25, 2000556 (2020).
27 Lechien, J. R. et al. Objective olfactory evaluation of self‐reported loss of smell in a case series of 86 COVID‐19 patients. Head Neck., doi: 10.1002/hed.26279 (2020).
28 Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol., 1-11 (2020).
29 Lechien, J. R. et al. Clinical and epidemiological characteristics of 1,420 European patients with mild‐to‐moderate coronavirus disease 2019. J Intern Med., doi: 10.1111/joim.13089 (2020).
30 Lee, D. J. et al. Self-reported anosmia and dysgeusia as key symptoms of COVID-19. CJEM., 1-19 (2020).
31 Levinson, R. et al. Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection. Infect Dis. 52, 600-602 (2020).
32 Liguori, C. et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun., doi: 10.1016/j.bbi.2020.05.037 (2020).
33 Luers, J. C. et al. Olfactory and gustatory dysfunction in Coronavirus disease 19 (COVID-19). Clin Infect Dis., doi: 10.1093/cid/ciaa525 (2020).
34 Meini, S., Suardi, L. R., Busoni, M., Roberts, A. T. & Fortini, A. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol., 1 (2020).
35 Mercante, G. et al. Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019. JAMA Otolaryngol Head Neck Surg., doi: 10.1001/jamaoto.2020.1155. (2020).
36 Paderno, A. et al. Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects. Otolaryngol Head Neck Surg., doi: 10.1177/0194599820939538 (2020).
37 Patel, A. et al. New onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2. Clin Microbiol Infect., doi: 10.1016/j.cmi.2020.05.026 (2020).
38 Petrocelli, M. et al. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol., 1-12 (2020).
39 Pinna, P. et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J Neurol Sci., doi: 10.1016/j.jns.2020.116969 (2020).
40 Renaud, M. et al. Acute smell and taste loss in outpatients: all infected with SARS-CoV-2? Rhinology., doi: 10.4193/Rhin20.199 (2020).
41 Sakalli, E. et al. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients. Am J Otolaryngol., doi: 10.1016/j.amjoto.2020.102622 (2020).
42 Sayin, İ., Yaşar, K. K. & Yazici, Z. M. Taste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative Study. Otolaryngol Head Neck Surg., doi: 10.1177/0194599820931820 (2020).
43 Sierpiński, R. et al. Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19. Pol Arch Intern Med., doi: 10.20452/pamw.15414 (2020).
44 Tostmann, A. et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro surveill., 25, 2000508 (2020).
45 Tsivgoulis, G. et al. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2](COVID-19). J Neurol., 1 (2020).
46 Vacchiano, V. et al. Early neurological manifestations of hospitalized COVID-19 patients. Neurol Sci., 1-3 (2020).
47 Vaira, L. A. et al. Objective evaluation of anosmia and ageusia in COVID‐19 patients: Single‐center experience on 72 cases. Head neck. 42, 1252-1258 (2020).
48 Vaira, L. A. et al. Olfactory and gustatory function impairment in COVID‐19 patients: Italian objective multicenter‐study. Head Neck., doi: 10.1002/hed.26269 (2020).
49 Vaira, L. A. et al. Validation of a self‐administered olfactory and gustatory test for the remotely evaluation of COVID‐19 patients in home quarantine. Head Neck., doi: 10.1002/hed.26228 (2020).
50 Yan, C. H., Prajapati, D. P., Ritter, M. L. & DeConde, A. S. Persistent Smell Loss Following Undetectable SARS-CoV-2. Otolaryngol Head Neck Surg., doi: 10.1177/0194599820934769. (2020).
51 Zayet, S. et al. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients. Infection., 1 (2020).
52 Zayet, S. et al. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes and infection (2020).
53 Chung, T. W.-H. et al. Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review. Open forum Infect Dis. 7, doi:10.1093/ofid/ofaa199 (2020).
54 Hintschich, C. A. & Wenzel, J. J. Psychophysical tests reveal impaired olfaction but preserved gustation in COVID-19 patients., Int Forum Allergy Rhinol., doi:10.1002/alr.22655 (2020).
55 Moein, S. T. et al. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 10, 944-950, doi:10.1002/alr.22587 (2020).
56 Paderno, A., Schreiber, A. & Grammatica, A. Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 10, 955-962, doi:10.1002/alr.22610 (2020).
57 Yan, C. H. & Faraji, F. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 10, 806-813, doi:10.1002/alr.22579 (2020).
58 Yan, C. H., Faraji, F., Prajapati, D. P., Ostrander, B. T. & DeConde, A. S. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 10, 821-831, doi:10.1002/alr.22592 (2020).
59 Hopkins, C., Surda, P. & Kumar, N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 10 (2020).
60 Han, A. Y., Mukdad, L., Long, J. L. & Lopez, I. A. Anosmia in COVID-19: Mechanisms and Significance. Chem senses. doi:10.1093/chemse/bjaa040 (2020).
61 Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395, 565-574 (2020).
62 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579, 270-273 (2020).
63 Cao, Y. et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 6, 1-4 (2020).
64 Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 34, 4121-4123 (2018).
65 Tang, X. et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev., doi: 10.1093/nsr/nwaa036 (2020).
66 Brufsky, A. Distinct Viral Clades of SARS‐CoV‐2: Implications for Modeling of Viral Spread. Journal of medical virology. J Med Virol., doi: 10.1002/jmv.25902. (2020).
67 Korber, B. et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell., doi: 10.1016/j.cell.2020.06.043 (2020).
68 Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 62, e1-e34 (2009).
69 Hoy, D. et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 65, 934-939 (2012).
70 Freeman, M. F. & Tukey, J. W. Transformations related to the angular and the square root. The Annals of Mathematical Statistics, 607-611 (1950).